Rho family GTP-binding proteins have been demonstrated to play a role in the regulation of phospholipase D (PLD) activity. In the present study, we examined the role of Rho proteins in PLD activation in differentiated HL-60 cells using C3 exoenzyme from Clostridium botulinum, which ADP-ribosylates and inactivates Rho proteins. Introduction of C3 exoenzyme into differentiated HL-60 cells by electroporation resulted in complete inhibition of PLD activity stimulated by formyl methionine-leucine-phenylalanine (fMLP) and ATP, two receptor agonists. Phorbol myristate acetate-induced PLD activation was also inhibited in C3 exoenzyme-treated cells, but the inhibition was only partial. GTPQS-dependent activation of PLD, measured in the absence or presence of ATP in permeabilized cells, was also partially affected by C3 exoenzyme treatment. Thus, these results indicate that Rho proteins play a key role in receptor-mediated PLD regulation in differentiated HL-60 cells, but play a partial role in the in vivo action of PMA and in vitro action of GTPQS on PLD. ATP produced a significant enhancement of the in vitro effect of GTPQS on PLD activity, but the effect of ATP was not altered by inhibitors of serine/threonine and tyrosine kinases. However, it was markedly reduced by neomycin and accompanied by an increase in phosphatidylinositol 4,5-bisphosphate (PtdInsP 2 ) synthesis. These data indicate that in permeabilized HL-60 cells, the stimulatory effect of ATP on PLD does not involve protein phosphorylation but is due to an increase in PtdInsP 2 . ß
Introduction
Phospholipase D (PLD), which catalyzes the hydrolysis of phosphatidylcholine to choline and phosphatidic acid, has been implicated in signal transduction in a variety of cell types and in the regulation of several cellular functions [1] . PLD is activated by many extracellular signals and multiple factors are involved in its cellular regulation [2] .
Activation of membrane-associated PLD by the non-hydrolyzable guanine nucleotide, guanosine 5P-O-(3-thiotriphosphate) (GTPQS) has been observed in reconstitution experiments when cytosol is present in the reaction mixture [3, 4] . Similar ¢ndings have been obtained in permeabilized cells in which the loss of cytosolic components resulted in the reduction of GTPQS-dependent PLD activity [5, 6] . Two kinds of small GTP-binding proteins, members of the ADP-ribosylation factor (Arf) and Rho families of proteins, have been identi¢ed as regulatory factors for PLD activity [7^11] . Arf, ¢rst identi¢ed as a cofactor necessary for the ADP-ribosylation of the K-subunit of the heterotrimeric G protein G s by cholera toxin [12, 13] , has been implicated in vesicular transport in the Golgi [14] . It was later described as an activator of PLD partially puri¢ed from several cell types and has now been shown to activate homogeneous preparations of certain PLD isozymes (for references, see [2] ). The presence of PtdInsP 2 is essential for the detection of Arf-regulated PLD activity in vitro [7] .
Rho proteins have been involved in the regulation of the assembly of focal adhesion complexes and actin stress ¢bers [15, 16] . Evidence for involvement of Rho family proteins, especially RhoA, in PLD activation comes from the demonstration that Rho GDI, a Rho speci¢c GDP dissociation inhibitor, inhibits activation of PLD by GTPQS [9, 10, 17, 18] . Furthermore, several toxins a¡ecting Rho proteins have been useful tools for researching Rho-mediated PLD regulation [19^22] . Clostridium botulinum C3 exoenzyme which speci¢cally ADP-ribosylates RhoA, B and C proteins and prevents their interaction with downstream targets [23] , has been shown to inhibit agonist-induced PLD activation in several cells [20, 21, 24] . However, it has also been reported to be ine¡ective in inhibiting GTPQS stimulation of PLD in neutrophils and liver plasma membranes [10, 18] .
Although the involvement of Rho and Arf family proteins in GTPQS-dependent activation of PLD has been extensively studied in vitro, their involvement in receptor-mediated PLD responses has been less investigated [22,25^27] . In HL-60 cells di¡erentiated along the granulocyte pathway, receptor-mediated activation of PLD by the chemotactic peptide, formyl methionine-leucine-phenylalanine (fLMP) and by ATP, which binds to P 2 -purinoceptors, has been demonstrated [28] , in agreement with the present ¢ndings. Evidence has also been provided that ARF and RhoA can stimulate PLD activity in the presence of GTPQS in in vitro preparations from these cells [7^9, 17] . The present work was performed to identify the physiological contribution of Rho proteins to PLD activation by investigating the e¡ect of C3 exoenzyme on receptor-mediated regulation of PLD in di¡erentiated HL-60 cells. The results demonstrate that Rho proteins play a major role in fMLP-and ATP-stimulated PLD activation in intact HL-60 cells. On the other hand, C3 exoenzyme had only a partial e¡ect on phorbol ester-induced PLD activation in the intact cell and on GTPQS-dependent activation of PLD in the permeabilized cells indicating the involvement of other mechanisms. Our results also show an important role for PtdInsP 2 synthesis and a lack of a role for protein phosphorylation in the enhancement by ATP of the stimulation of PLD by GTPQS in vitro.
Experimental procedures

Materials
HL-60 human promyelocytic leukemic cell line was from American Type Culture Collection (Rockville, MD). RPMI 1640, and M199 media and fetal bovine serum came from Irvine Scienti¢c (Santa Ana, CA). Cytochalasin B, formyl-Met-Leu-Phe (fMLP), 4L-phorbol 12-myristate 13-acetate (PMA), dibutyryl cyclic AMP (Bu 2 cAMP), inositol phospholipid standards and L-escin were obtained from Sigma. 3 H]inositol were from Du Pont-NEN. Silica-gel plates were purchased from Whatman. 1,2-Dioleoyl-sn-glycero-3-phosphobutanol (PtdBuOH) was from Avanti Polar Lipids (Birmingham, AL). C. botulinum C3 exoenzyme was from List Biological Laboratories (Campbell, CA).
Cell culture and cell labeling
HL-60 cells were grown in RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS), 100 units/ml penicillin and 100 Wg/ml streptomycin. Cells were grown at a density of 0.32 .0U10
6 cells/ml in a humidi¢ed atmosphere containing 5% CO 2 at 37³C. To induce di¡erentiation, the cells (1.0U10 6 /ml) were incubated in RPMI 1640 medium supplemented with 1% FBS, 100 units/ml penicillin, 100 Wg/ml streptomycin and 500 WM Bu 2 -cAMP for 3 days. [ 3 H]Myristic acid (1 WCi/ml) was added 18 h before the end of cell di¡erentiation.
For electroporation, di¡erentiated HL-60 cells were harvested, washed once with 125 mM NaCl, 5 mM KC1, 1 mM MgCl 2 , 25 mM HEPES, 5 mM glucose and 1 mg/ml BSA, pH 7.4 (bu¡er A), then with 120 mM potassium glutamate, 20 mM potassium acetate, 20 mM HEPES, 1 mM EGTA, 5 mM glucose and 1 mg/ml BSA, pH 7.4 (bu¡er B) and resuspended in this bu¡er at 1.0U10 7 cells/ml. Aliquots (0.8 ml) of cells were transferred into Bio-Rad pulser cuvettes and permeabilized at room temperature using one discharge of 250 V from a 960 WF capacitor. After 10 min the cells were transferred to RPMI 1640 medium containing 5% FBS and [ 3 H]myristic acid (1 WCi/ml) for 18^20 h before PLD activity determination. Cell viability was estimated by trypan blue exclusion. Cell survival after electroporation was usually reduced (about 40^60%). However, no signi¢cant di¡erences were observed between viable cells electroporated in the presence or absence of C3 exoenzyme.
Determination of PLD activity
Labeled HL-60 cells were harvested, washed with bu¡er A containing 1 mM CaCl 2 [29] . The chloroform phase was dried and dissolved in 20 Wl chloroform. These samples were spotted on silica gel plates. The plates were developed using the upper phase of a mixture consisting of ethylacetate/trimethylpentane/acetic acid/water (13:2:3:10, v/v) for the separation of PtdBuOH. The plates were stained with iodine vapor to locate the standard PtdBuOH and scraped. The radioactivity associated with PtdBuOH was quanti¢ed by liquid scintillation and expressed as a percentage of the total radioactivity in the phospholipids (about 70 000 cpm).
ADP-ribosylation by C3 exoenzyme
HL-60 cells were pelleted by centrifugation, washed in ice-cold bu¡er containing 50 mM HEPES, 1 mM EGTA and 1 mM EDTA, pH 7.4 and sonicated for 10 s. Cell lysate was incubated in the presence of 500 ng of C. botulinum C3 exoenzyme,
(1 WCi, 350 Ci/mmol, ICN), 10 mM dithiothreitol, 5 mM MgCl 2 , 1 mM EDTA, 10 mM thymidine, 1 mM ATP, 100 WM GTP and 2 WM NAD at 30³C for 1 h. The reaction was stopped by adding ice-cold acetone. Precipitates were analyzed by SDS-PAGE and autoradiography.
Determination of inositol phospholipid levels
HL-60 cells were di¡erentiated in M199 medium supplemented with 100 units/ml penicillin, 100 Wg/ml streptomycin, 5 Wg/ml insulin, 5 Wg/ml transferrin, 5 ng/ml sodium selenite, 4 WM glutamine, 1.75 mg/ ml BSA and 500 WM bu 2 cAMP for 3 days. myo- 
Results
PLD activation by the two receptor agonists, ATP and fMLP, can be observed in [
3 H]myristic acid-labeled HL-60 cells after 3 days of bu 2 cAMP-induced di¡erentiation. PMA, a PKC activator, is also known to activate PLD in various cell types including HL-60 cells. To determine the role of Rho proteins in these responses, we introduced C3 exoenzyme from C. botulinum into di¡erentiated HL-60 cells by electroporation and examined the PLD responses 20 h later. Fig. 1A illustrates the time course of PLD activation by 1 WM fMLP and 100 WM ATP in HL-60 cells electroporated with and without C3 exoenzyme 1 . Fig. 1B shows that both responses were completely abolished by treatment with 1 Wg/ml C3 exoenzyme. Activation of PLD induced by 100 nM PMA was also a¡ected by C3 exoenzyme treatment, but the inhibition was only 32% (Fig. 1C) .
The e¡ect of C3 exoenzyme on PLD activation in di¡erentiated HL-60 cells was correlated with the ADP-ribosylation of Rho proteins. To prove in situ ADP-ribosylation of Rho proteins, HL-60 cells were electroporated in the presence or absence of 1 Wg/ml C3 exoenzyme, homogenized after 20 h and incubated with C3 exoenzyme and [
32 P]NAD. Incorporation of [ 32 P]ADP into Rho proteins was observed, and was signi¢cantly lower in lysates from C3 exoenzyme-treated cells than in those from control cells, indicating that Rho was ADP-ribosylated in situ by the exoenzyme (Fig. 2) . Since incorporation of [ 32 P]ADP into C3 exoenzyme-treated Rho proteins was 16 þ 1% of control (n = 4), a large fraction of Rho was ADP-ribosylated in the cells. We also investigated the e¡ect of C3 exoenzyme on phosphoinositide levels in di¡erentiated HL-60 cells. This was because Rho family proteins have been implicated in regulating the synthesis of PtdInsP 2 [33, 34] , a cofactor for PLD activation [7] . Di¡erentiated HL-60 cells were electroporated in the presence or absence of 1 Wg/ml C3 exoenzyme and incubated with [ 3 H]inositol (2 WCi/ml) for 20 h before determination of radioactive phosphoinositide levels. In three independent experiments, we found no signi¢cant di¡erence in total incorporation of [ 3 H]inositol into phosphoinositides (175 000 þ 7 700 cpm vs. 163 000 þ 14 700 cpm). However, we observed an increase of PtdInsP 2 from 0.7 þ 0.2% of total radioactive incorporation in control cells to 1.0 þ 0.2% in C3 exoenzyme-treated cells. The treatment also caused an increase of PtdInsP from 1.4 þ 0.3% of total radioactive incorporation to 2.4 þ 0.2%. These results exclude the possibility that C3 exoenzyme a¡ected PLD stimulation in di¡eren-tiated HL-60 cells by inhibiting PtdInsP 2 synthesis.
As has been extensively reported, PLD activity is strongly enhanced when GTPQS is introduced into permeabilized HL-60 cells, indicating the involvement of a GTP-binding protein(s) in the regulation of the enzyme. We observed that, in di¡erentiated and L-escin-permeabilized HL-60 cells, this GTPQSstimulated PLD response was potentiated by ATP (Fig. 3) . Millimolar ATP was required to observe this e¡ect since 10 WM and 100 WM ATP were ineffective (data not shown). It should also be noted that, in the absence of guanine nucleotide, ATP induced only a very modest accumulation of PdtBuOH (see Fig. 6 ). Because a non-phosphorylating analog of ATP, AMP-PNP, did not potentiate PtdBuOH formation (Fig. 3) , it appeared that ATP acted as a phosphoryl group donor in the reaction.
We used L-escin-permeabilized HL-60 cells as an experimental system to investigate the contribution of Rho proteins to the GTPQS-dependent activation of PLD and its potentiation by ATP. After electroporation of di¡erentiated HL-60 cells with or without C3 exoenzyme (1 Wg/ml) and a 20 h recovery period, cells were permeabilized by L-escin and stimulated by GTPQS alone (1 WM^1 mM) or GTPQS plus ATP (1 mM). While the basal PLD activity was not signi¢cantly a¡ected by C3 exoenzyme treatment, PLD activation induced by 1 mM GTPQS was inhibited by 26 þ 4% in C3 exoenzyme-treated cells (Fig.  4) . Similar inhibition (22^32%) was observed at other GTPQS concentrations. The PLD response observed in the presence of GTPQS plus ATP was also inhibited by C3 exoenzyme (20 þ 4%). There was also in- hibition of the small accumulation of PdtBuOH caused by ATP itself (data not shown). These data thus indicated that Rho proteins made a minor contribution to GTPQS-induced PLD activation in vitro 2 .
To investigate the mechanism underlying the potentiation by ATP of GTPQS-dependent PLD activation in di¡erentiated HL-60 cells, we examined the e¡ect of di¡erent protein kinase inhibitors on this response. No signi¢cant inhibition of the PLD activation induced by GTPQS plus ATP was observed when di¡erentiated HL-60 cells were preincubated 10 min before their stimulation with the Ser/Thr kinase inhibitor staurosporine at 5 WM (13.9 þ 0.9% and 15.5 þ 0.3% of total radioactive phospholipids, without and with inhibitor, n = 3) or with the selective protein kinase C inhibitor bisindolylmaleimide at 5 WM (13.8 þ 1.4% and 12.2 þ 1.1% of total radioactive phospholipids, without and with inhibitor, n = 3), although both inhibitors blocked the PMAinduced PLD response at this concentration (data not shown). Among the tyrosine kinase inhibitors used (100 WM tyrphostin A, 50 WM erbstatin, 20 WM ST638, 20 WM lavendustin, 20 WM herbimycin and 10^199 WM genistein), only genistein showed a signi¢cant inhibition of the potentiation by ATP of the GTPQS-dependent activation of PLD. However, this inhibition was partial and was only observed with high concentrations (100 WM) of genistein (13.1 þ 0.4% and 9.6 þ 0.4% of total radioactive phospholipids, without and with genistein). At this concentration, genistein is not considered to be a selective tyrosine kinase inhibitor and is capable of inhibiting lipid kinases such as phosphatidylinositol 4-phosphate 5-kinase [30] .
Since the use of protein kinase inhibitors did not provide evidence for a role of protein phosphorylation in the potentiation by ATP of GTPQS-dependent PLD activation, we tested the hypothesis that this e¡ect could be a consequence of phospholipid phosphorylation. Considering that PtdInsP 2 is an essential factor for PLD activation in vitro [7] , synthesis of PtdInsP 2 in the presence of 1 mM ATP was examined in permeabilized HL-60 cells. (Fig. 5) . When [
3 H]inositol-labeled cells were treated with both GTPQS (100 WM) and ATP (1 mM), the increases in the labeled inositol phospholipids were similar to those induced by ATP alone (Fig. 5 ). To further demonstrate that ATP could contribute to PLD activation by inducing PtdInsP 2 synthesis in di¡erentiated HL-60 cells, we also used neomycin, a cationic aminoglycoside antibiotic that exhibits high binding a¤nity for inositol phospholipids, especially PtdInsP 2 [31, 32] . Fig. 6 shows that incubation of intact di¡erentiated HL-60 cells in the presence of neomycin for 10 min did not signi¢cantly a¡ect GTPQS-dependent PLD activation, but prevented the potentiation by ATP of the GTPQS e¡ect. Indeed, potentiation by ATP was completely abolished by 600 WM neomycin. Neomycin also inhibited the small PLD activation caused by ATP itself.
Discussion
Identi¢cation of Rho as regulatory factor of PLD was ¢rst indicated by the observation that Rho GDI, which extracts Rho proteins from membranes, prevented GTPQS-dependent activation of PLD in HL-60 [18] and rat liver [10] membranes. PLD activation was restored by the addition of RhoA [10, 33] . Siddiqi et al. [9] showed that not only RhoA but also Rac1 and Cdc42Hs induced PLD activation in HL-60 cell membranes. The e¡ect of RhoA has been con¢rmed by Martin et al. [34] , but these workers were unable to see an e¡ect of Rho GDI and concluded that the stimulatory e¡ect of GTPQS on PLD in HL-60 cell membranes was mediated by endogenous Arf [34] .
The present study employed C. botulinum C3 exoenzyme to determine the physiological role of Rho proteins in receptor-mediated regulation of PLD in intact di¡erentiated HL-60 cells. This exoenzyme has been demonstrated to ADP-ribosylate RhoA 100-fold more e¤ciently than Rac1 and 400-fold more e¤ciently than Cdc42Hs [15] and to selectively block Rho-mediated changes in intact cells [35^38] . Thus it is reasonable to ascribe its e¡ects as due to inactivation of Rho in the present study.
The exoenzyme inactivates Rho proteins in vitro but enters intact cells poorly [39] . We found that cell electroporation allowed the introduction of C3 exoenzyme into the cells and the ADP-ribosylation of 84% of the endogenous Rho (Fig. 2) . The electroporation alone did not alter the response of the cells to agonists (Fig. 2) . This made it possible to study the role of Rho proteins in an intact cellular system. Our results show that fMLP-and ATP-stimulated PLD activity was completely suppressed in C3 exoenzyme-treated cells (Fig. 1) , demonstrating a key role for Rho proteins. The mechanism(s) by which these proteins activate PLD in intact cells is unclear, but GTPQS-activated forms of recombinant RhoA, Rac1 and Cdc42Hs have been shown to activate homogeneous preparations of the hPLD1 and rPLD1 isozymes of PLD in vitro [40^42]. Thus direct interaction of these Rho family proteins with these PLD isozymes produces a large increase in PLD activity [40^42] . It has also been shown that treatment of Swiss 3T3 cells with agonists in vivo or GTPQS in vitro induces membrane translocation of Rho family proteins [43] . Therefore it is possible that agonists could induce the activation and translocation of these proteins to cellular sites enriched in PLD, leading to activation of the enzyme.
Another possibility is that the action of RhoA proteins on PLD is indirect. Jakobs and associates [44] have proposed that C3 exoenzyme and Toxin B from C. di¤cile inhibit PLD activation through a reduction in PtdInsP 2 synthesis. As noted above, this lipid is essential for stimulation of PLD in vitro [7, 45, 46] and there is evidence that Rho family proteins play a role in its synthesis by PtdInsP 5-kinase [47, 48] . Furthermore, as shown for HL-60 cells in the present study, the addition of MgATP to permeabilized HEK cells enhanced the e¡ect of GTPQS on PLD activity [44] . This was associated with an increase in PtdInsP 2 and was blocked by neomycin [44] . Toxin B produced a partial inhibition of PLD activity which could be reversed by addition of PtdInsP 2 to the permeabilized cells.
Despite the strong evidence that PtdInsP 2 can control PLD activity in vitro and in permeabilized cells [7,41,44^46,49] , it is less clear that it can do so in vivo. For example, although treatment of HEK cells with 50 Wg/ml Toxin B for 24 h produced a 40% reduction of PtdInsP 2 [44] it was not demonstrated that this was responsible for the virtual abolition of agonist activation of PLD in these cells [26] . In the present study, we failed to see decreases in PtdInsP or Ptd InsP 2 in cells treated with C3 exoenzyme under the same conditions that PLD activity was measured. In fact, the reagent produced 40^70% increases in these lipids. We did not determine the basis for these increases, but they clearly exclude a decrease in PtdInsP 2 as a mechanism for the e¡ect of C3 exoenzyme on PLD activity in our experiments.
Despite the abolition of agonist-induced PLD activation in intact HL-60 cells by C3 exoenzyme, the activation of PLD by GTPQS in vitro was only partly decreased. One explanation is that the 84% inactivation of total cellular induced Rho by C3 exoenzyme was still insu¤cient to completely block the action of this G protein in the L-escin-permeabilized cells. This possibility is supported by the ¢nding that complete glucosylation of Rho proteins induced by Toxin B caused abolition of the PLD response to GTPQS in HL-60 lysates [19] , and that C3 exoenzyme produced a 65% inhibition of the e¡ect in HL-60 cell membranes [24] . Likewise, Schmidt et al. [26, 44] observed 60^80% inhibition of the PLD response by C3 exoenzyme and Toxin B, respectively, in digitonin-permeabilized HEK cells, and a large inhibition has been reported in basophilic leukemia cells [22] . Summarizing all these reports, Rho appears to play a signi¢-cant role in the e¡ect of GTPQS on PLD in permeabilized cells or cell lysates.
In agreement with other studies with Clostridial toxins [10, 22, 26] , C3 exoenzyme produced less inhibition of the PLD activation induced by PMA compared with that caused by agonists. This suggests that PKC-mediated activation of PLD is less dependent on Rho proteins. There is evidence that conventional PKC isozymes can directly activate certain PLD isozymes [11, 40, 41] and this could explain the Rho-independent activation of PLD by PMA. Concerning the Rho-dependent mechanism, this could involve Rho proteins as downstream mediators of certain PKC actions, or could arise from the demonstrated ability of RhoA and PKCK to interact synergistically to activate PLD [11, 17, 49] .
The incomplete inactivation of the GTPQS-induced PLD in vitro response by C3 exoenzyme observed in the present and other [24, 26] studies raises the possibility that another small GTP-binding protein in involved. A likely candidate is a member(s) of the Arf family because of their known stimulatory e¡ects on PLD in vitro [7^9,11] . However, our previous e¡orts to prove this in permeabilized cells using brefeldin A, an inhibitor of Arf activation, [50] were unsuccessful. Furthermore, when arfaptin 1, an Arf binding protein [51] and inhibitor of Arf action of PLD [58] , was introduced in HL-60 cells by electroporation or added to the permeabilized cells, no inhibition of GTPQS activation of PLD was observed (I. Guillemain, J.H. Exton, unpublished observations). Expression of constitutively active L71 Arf3 in COS7 cells was also unable to activate co-expressed rPLD1 [52] . Thus it has been di¤cult to demonstrate Arf regulation of PLD in an intact or permeabilized cell setting, perhaps because of the presence of arfaptin [51] or other inhibitory proteins. It is possible that the regulation of PLD by Arfs in intact cells may be con¢ned to the Golgi or plasma membrane [53, 54] . This question needs further work since a recent report has implicated Arf in the regulation of PLD by fMLP in streptolysin O-permeabilized neutrophils [55] .
The failure of any Ser/Thr protein kinase inhibitor to in£uence the potentiation by ATP of the stimulation of PLD by GTPQS in the permeabilized cells was somewhat surprising since synergistic interaction between conventional PKC isozymes and Rho or Arf in the regulation of PLD has been well demonstrated [11, 33, 40, 49] . The presence of PKC in the permeabilized cells was demonstrated by the stimulatory e¡ect of PMA, which was blocked by PKC inhibitors (data not shown). On the other hand, the action of ATP was attributable to an increase in PtdInsP 2 since the nucleotide induced a 3-fold increase in this lipid (Fig. 5 ) and its action on PLD was blocked by neomycin, as observed in permeabilized neutrophils [56] . An increase in PtdInsP 2 with ATP has also been observed in other studies with HL-60 cell mem-branes [49] and permeabilized HEK and U937 cells [44, 46] . Interestingly, ATP alone did not increase PLD activity and addition of GTPQS was necessary to see its e¡ect.
In summary, the present results point to a major role for Rho proteins in the stimulation of PLD by fMLP and ATP in HL-60 cells, but only a partial role in the e¡ect of PMA. However, the mechanism of action of Rho proteins on PLD activity in the intact cells is still not de¢ned and the role, if any, of Arf in the mediation of agonist stimulation of PLD in these cells remains unclear. Thus considerable further work is required to de¢ne exactly how PLD is regulated by Rho and Arf in intact cells.
